Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired

The financial statements of Peaks Curative, LLC. required by Item 9.01(a) to this Current Report on Form 8-K are incorporated herein by reference to (i) Peaks Curative, LLC's audited consolidated balance sheets as of and for the years ended September 30, 2021, and 2022.

The financial statements of RxCompoundStore.com, LLC. required by Item 9.01(a) to this Current Report on Form 8-K are incorporated herein by reference to (i) RxCompondStore.com, LLC's audited consolidated balance sheets as of and for the years ended March 31, 2021, and 2022.

(b) Pro Forma Financial Information



The pro forma financial information required by Item 9.01(b) to this Current
Report on Form 8-K is incorporated herein by reference to the unaudited pro
forma.

(d) Exhibits

Exhibit No.   Description
2.1             Agreement and Plan of Merger
23.1            Bolko & Company, an independent registered public accounting firm
              of Peaks Curative, LLC.
23.2            Bolko & Company, an independent registered public accounting firm
              of RxCompoundStore.com, LLC.
99.2            Audited Consolidated Balance Sheets of Peaks Curative, LLC. as of
              September 30, 2022, and the Audited Consolidated Statements of
              Operations, Comprehensive Income/(Loss), and Cash Flows of Peaks
              Curative, LLC. for the period ended September 30, 2022.
99.3            Audited Consolidated Balance Sheets of RxCompoundStore.com, LLC.
              as of March 31, 2022, and the Audited Consolidated Statements of
              Operations, Comprehensive Income/(Loss), and Cash Flows of
              RxCompoundStore.com, LLC. for the period ended March 31, 2022.
99.4            Unaudited Pro Forma
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses